Ethics & Informed Consent: Qualitative Interview & Focus Group Research (Belgium)
A detailed academic review of the ethical submission protocol, informed consent prerequisites, and reporting standards for conducting a Qualitative Interview & Focus Group Research within the regulatory framework of Belgium.
1. Ethical Principles & Legislative Framework
In research involving human participants, securing ethical clearance is a critical first step. For a Qualitative Interview & Focus Group Research being conducted in Belgium, study designs must align with the primary regulatory legislation: Belgian Law of 7 May 2004 on Experiments on the Human Person. This statutory framework ensures participant welfare, confidentiality, and voluntary involvement are protected.
National Ethics Board Clearance Pathway
In Belgium, clinical trials are reviewed by an accredited Ethics Committee. All applications must detail insurance cover and satisfy strict GDPR data processing provisions.
Administrative review and formal approval are managed by a local or regional Ethics Committee (Comité d'Éthique / Ethisch Comité). Researchers must secure full approval or a formal exemption certificate from this board before recruiting any participants or commencing data collection.
2. Study Design Elements & Reporting Integrity
For a Qualitative Interview & Focus Group Research, the review board places significant focus on methodological transparency. The application must outline the research rationale, recruitment protocols, inclusion and exclusion criteria, and data protection measures.
Study Classification: Minimal Risk
This qualitative study captures conversational transcripts. Informed consent must outline de-identification procedures and note that focus group settings have inherent privacy limits.
To guarantee academic integrity and reproducibility, the study report and subsequent publications should follow the internationally recognised reporting standard: COREQ checklist.
Special Directive: Observational Study Protocols
As an observational or non-interventional design, the ethics board primarily focuses on data privacy, secure pseudonymisation, and informed consent. If you are conducting retrospective database research, you may apply for a waiver of consent, provided participant risk is minimised.
3. Informed Consent & Information Sheet Guidelines
A robust participant information sheet and informed consent form are critical parts of the ethical application. Ensure your documentation incorporates the following components:
Design-Specific Consent Focus Areas
Voice recording permission, use of direct quotations in publications, focus group confidentiality limitations.
- Plain Language Explanations: Avoid complex medical or technical terminology. Ensure readability matches the general population.
- Voluntary Participation: Explicitly state that participation is entirely voluntary and that individuals can withdraw at any time without negative consequences.
- Confidentiality & Data Controls: Explain how participant data will be anonymised or pseudonymised, who will have access to it, and how long it will be securely retained under EU GDPR & Belgian Privacy Act.
- Risk/Benefit Disclosure: Clearly list any potential risks, discomforts, or direct benefits associated with participation in the study.
- Ethics Board Contact Information: Provide the contact details of the reviewing Ethics Committee (Comité d'Éthique / Ethisch Comité) so participants can reach out if they have questions or concerns.
Research Ethics, Clinical Trials & Institutional Governance
Protecting dialogue records in this Qualitative Interview & Focus Group Research in Belgium is based on the Belmont Report principles of respect and privacy. Any study requiring any deception in psychological research must be pre-approved by the Ethics Committee (Comité d'Éthique / Ethisch Comité) with a thorough debriefing plan. Providing a detailed research study consent form guarantees alignment with informed consent Belmont Report requirements. Although qualitative designs do not require a clinical trial registration, securing a signed clinical trial agreement contract is often required for hospital sites. These non-clinical studies do not involve animal models regulated by the 3rs replacement reduction refinement guidelines. In accordance with Belgium participant safety rules, investigators must complete certified human protection modules before recruitment begins.
4. Regulatory Checklist Table
To streamline your ethical review submission, use the structured alignment checklist below:
| Requirement | Ethics Committee (Comité d'Éthique / Ethisch Comité) Standard | COREQ checklist Standard |
|---|---|---|
| Consent Form | Signed and dated prior to study activity. Focus: Voice recording permission. | Fully documented recruitment and consent paths. |
| Risk Management | Comprehensive risk mitigation plan. Pseudonymisation of interview transcripts, secure digital recording storage, prompt deletion of raw audio files post-transcription. | Adverse events reporting strategy. |
| Data Retention | Compliance with local data protection rules (EU GDPR & Belgian Privacy Act). | Provision of open-data options where possible. |
5. Academic & Research Infrastructure Matrix (Belgium)
The following authenticated registry lists top scientific organizations, clinical laboratories, and research hospitals in Belgium mapped via the Research Organization Registry (ROR) standards-compliance framework.
| Organization Name | Sector Type | Registry Identification |
|---|---|---|
| Janssen (Belgium) | company | ROR IDWikidata/Wiki |
| Bayer (Belgium) | company | ROR IDWikidata/Wiki |
| Fujirebio (Belgium) | company | ROR IDWikidata/Wiki |
| 3E (Belgium) | company | ROR ID |
| ATiT (Belgium) | company | ROR ID |
| CropDesign (Belgium) | company | ROR ID |
| Custodix (Belgium) | company | ROR ID |
| Barco (Belgium) | company | ROR IDWikidata/Wiki |
| Bekaert (Belgium) | company | ROR IDWikidata/Wiki |
| Alstom (Belgium) | company | ROR IDWikidata/Wiki |
| Belgonucleaire (Belgium) | company | ROR ID |
| Belgoprocess (Belgium) | company | ROR ID |
| CISSOID (Belgium) | company | ROR ID |
| ArcelorMittal (Belgium) | company | ROR IDWikidata/Wiki |
| Aquaplus (Belgium) | company | ROR ID |
6. Frequently Asked Questions
How long does the review process normally take?
Review timelines depend on the volume of applications and whether your proposal qualifies for expedited review. On average, a standard review by an ethics board in Belgium takes between 4 to 8 weeks.
Can we use digital signatures for informed consent?
Yes, digital consent forms are increasingly accepted, provided the platform used is secure, authenticates the identity of the signer, and complies with local regulations such as the eIDAS or ESIGN Act, depending on country-specific rules.
Regulatory Context
Verified Funding Bodies
Funder registries and DOI configurations verified for compliance in Belgium via Crossref.
- European Marine Biological Resource Centre BelgiumID: 501100015737 | Location: Belgium
- Lilly BelgiëID: 100032698 | Location: Belgium
- U.S. Embassy in BelgiumID: 100023644 | Location: Belgium
- UCBID: 100011110 | Location: Belgium
- Union Chimique BelgeID: 100016879 | Location: Belgium
- Belgische Federale OverheidsdienstenID: 100018214 | Location: Belgium
- Geological Survey of BelgiumID: 501100019192 | Location: Belgium
- Janssen PharmaceuticaID: 100008897 | Location: Belgium
- Fédération Wallonie-BruxellesID: 501100002910 | Location: Belgium
- Nationale Bank van BelgiëID: 100031012 | Location: Belgium
Pre-Submission Warning
Do not recruit participants or initiate study procedures before receiving official written approval from your reviewing board. Ethical approvals cannot be granted retrospectively under Belgian Law of 7 May 2004 on Experiments on the Human Person.







